rifampicin
Showing 1 - 25 of 100
Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)
Enrolling by invitation
- Drug Interactions
- Methotrexate Sodium
- Rifampicin
-
Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Oct 25, 2023
Multiple Sclerosis Trial in Saint Paul (Tolebrutinib, gemfibrozil, rifampicin)
Completed
- Multiple Sclerosis
- Tolebrutinib
- +2 more
-
Saint Paul, MinnesotaPrism Research-Site Number:8400001
Sep 26, 2023
Erectile Dysfunction Trial in Shanghai (TPN171H, Itraconazole, Rifampicin)
Completed
- Erectile Dysfunction
- TPN171H
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Oct 17, 2023
Tuberculous Meningitis Trial in Worldwide (Rifampicin (RIF), Isoniazid (INH), Linezolid (LZD))
Not yet recruiting
- Tuberculous Meningitis
- Rifampicin (RIF)
- +6 more
-
Porto Alegre, Brazil
- +9 more
Dec 14, 2022
Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)
Not yet recruiting
- Tuberculous Meningitis
- High dose rifampicin (25mg/kg)
- +8 more
-
Chennai, Tamil Nadu, IndiaICMR- National Institute for Research in Tuberculosis
Jun 15, 2023
Diabetes Trial in Gieres (Sotagliflozin (SAR439954), Rifampicin)
Completed
- Diabetes Mellitus
- Sotagliflozin (SAR439954)
- Rifampicin
-
Gieres, FranceInvestigational Site Number 250001
Apr 21, 2022
Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease Trial in Ruddington (Belumosudil, Itraconazole, Rabeprazole)
Completed
- Drug-drug Interaction
- +2 more
- Belumosudil
- +4 more
-
Ruddington, Nottingham, United KingdomQuotient Sciences Ltd
May 9, 2022
Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)
Recruiting
- Pulmonary Tuberculosis
- Other Specified Pulmonary Tuberculosis
- Sutezolid
- +6 more
-
Lambaréné, Gabon
- +7 more
Apr 17, 2023
Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)
Recruiting
- Tuberculosis, Pulmonary
- Sanfetrinem Cilexetil
- +2 more
-
Cape Town, Western Cape, South AfricaTASK Clinical Research Centre
May 19, 2022
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- +4 more
-
Tempe, ArizonaCelerion
Aug 15, 2023
Healthy Subjects Trial in Beijing (SKLB1028, Itraconazole, Gemfibrozil)
Active, not recruiting
- Healthy Subjects
- SKLB1028
- +3 more
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Sep 26, 2021
Leprosy Trial in Anjouan, Mohéli, Miandrivazo (Rifampicin)
Active, not recruiting
- Leprosy
- Rifampicin
-
Anjouan, Comoros
- +2 more
Sep 20, 2022
Solid Tumors Trial in Bruxelles, Wilrijk (BI 907828, Rifampicin)
Recruiting
- Solid Tumors
- BI 907828
- Rifampicin
-
Bruxelles, Belgium
- +4 more
Jan 9, 2023
Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)
Recruiting
- Tuberculosis, Pulmonary
- rifampicin
- +3 more
-
Linköping, SwedenLinköping University Hospital
Aug 19, 2021
Pediatric HIV Infection, Tuberculosis Infection Trial (rifampicin)
Not yet recruiting
- Pediatric HIV Infection
- Tuberculosis Infection
- rifampicin
- (no location specified)
Sep 26, 2021
Tuberculosis Trial in Cape Town (phenotyping cocktail, rifampicin)
Completed
- Tuberculosis
- phenotyping cocktail
- rifampicin
-
Cape Town, South Africa
- +1 more
Aug 16, 2021
Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions Trial (drug, behavioral, dietary supplement, other)
Not yet recruiting
- Severe Acute Malnutrition
- +3 more
- Rifampicin
- +8 more
- (no location specified)
Aug 8, 2023
Osteoarticular Infection Trial in France (Rifampicin)
Completed
- Osteoarticular Infection
- Rifampicin
-
Angers, France
- +15 more
Aug 20, 2021
Pulmonary Tuberculosis, Body Weight Changes, Motor Activity Trial (Rifampicin, Isoniazid, Pyrazinamide)
Completed
- Pulmonary Tuberculosis
- +2 more
- Rifampicin
- +4 more
- (no location specified)
May 23, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic sampling - AZD9291, Rifampicin, AZD9291 tablet dosing)
Completed
- Non Small Cell Lung Cancer
- Pharmacokinetic sampling - AZD9291
- +4 more
-
Atlanta, Georgia
- +17 more
Jun 18, 2021
Infections, Bacterial Trial in Las Vegas (Gepotidacin, Cimetidine, Rifampicin)
Completed
- Infections, Bacterial
- Gepotidacin
- +5 more
-
Las Vegas, NevadaGSK Investigational Site
Dec 9, 2021